Chairman of the Board of Directors of Merck Group in Germany: Investment Strategy in China Will Not Change Executive Officer | Merck Group | Merck Group in Germany
Beren Gariho, Chairman and CEO of Merck Group in Germany, recently stated that decoupling will result in huge economic costs, and Merck Group's investment strategy in China will not change.
During a press club event in Frankfurt, Germany on the evening of the 6th, Gariho stated that despite geopolitical tensions, Merck Group's investment strategy in China will not change.
She said that "decoupling" will bring huge economic costs, and when I hear politicians say "decoupling", I think it is not feasible... endangering a world that has already brought us prosperity, more innovation, and more cooperation.
Merck Group was founded in 1668, with a focus on innovative pharmaceuticals, life sciences, and cutting-edge functional materials technology. According to its company website, China is Merck Group's second largest market globally and the most important growth engine.